Published in Gynecol Oncol on January 01, 1991
Long-term results of radiotherapy in primary carcinoma of the vagina. Strahlenther Onkol (2009) 0.90
Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol (2015) 0.80
Radiotherapy for carcinoma of the vagina. Immunocytochemical and cytofluorometric analysis of prognostic factors. Strahlenther Onkol (2013) 0.80
Prognostic Factors in Primary Vaginal Cancer: A Single Institute Experience and Review of Literature. J Obstet Gynaecol India (2015) 0.75
Lymphoscintigraphy with 123I-labelled epidermal growth factor. Lancet (1991) 1.37
Lymphogenous metastasis in the primary carcinoma of the fallopian tube. Gynecol Oncol (1994) 1.08
Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Br J Cancer (1993) 1.04
Primary malignant melanoma of the vagina: long-term remission following radiation therapy. Gynecol Oncol (1998) 0.95
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer (1993) 0.93
Prognostic factors for survival in stage I epithelial ovarian carcinoma. Cancer (1990) 0.86
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Br J Cancer (1994) 0.86
Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma. Br J Obstet Gynaecol (1990) 0.85
Influence of delayed diagnosis on established prognostic factors in endometrial cancer. Anticancer Res (1996) 0.85
Radical lymphadenectomy in the primary carcinoma of the fallopian tube. Arch Gynecol Obstet (1993) 0.84
Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer. Eur J Cancer Clin Oncol (1989) 0.82
BRCA1 gene mutations in sporadic ovarian carcinomas: detection by PCR and reverse allele-specific oligonucleotide hybridization. Clin Chem (1999) 0.82
Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study. Gynecol Oncol (1997) 0.81
Does T1, N0-1 vulvar cancer treated by vulvectomy but not lymphadenectomy need inguinofemoral radiation? Int J Radiat Oncol Biol Phys (1997) 0.79
[Ferritin level in newborn infants after prepartal iron medication]. Geburtshilfe Frauenheilkd (1991) 0.79
[Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?]. Gynakol Rundsch (1990) 0.78
In vitro and in vivo evaluation of the combination of cisplatin and its analogue carboplatin for platinum dose intensification in ovarian carcinoma. Cancer (1993) 0.78
Detection of an atypical invasive mole in an ectopic pregnancy by transvaginal color-flow Doppler. Am J Obstet Gynecol (1993) 0.77
[PAP IV in pregnancy--a retrospective multicenter study]. Geburtshilfe Frauenheilkd (1991) 0.77
[Surgery in the treatment concept of epithelial ovarian cancer]. Gynakol Rundsch (1990) 0.76
[Value of irradiation alone of generally inoperable endometrial cancer with high dose rate iridium 192]. Geburtshilfe Frauenheilkd (1990) 0.76
Ultrasonic Doppler flow studies of the uterine arteries in women with cervix cancer. Gynecol Obstet Invest (1991) 0.76
Lymphoscintigraphy using epidermal growth factor as tumour-seeking agent in uterine cervical cancer. Wien Klin Wochenschr (1991) 0.75
CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br J Cancer (1998) 0.75
Primary fallopian tube carcinoma--a retrospective survey of 51 cases. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Arch Gynecol Obstet (1994) 0.75
Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinoma. Arch Gynecol Obstet (1994) 0.75
Evaluation of adjuvant therapy after surgery for primary carcinoma of the fallopian tube. Arch Gynecol Obstet (1994) 0.75
Cervical assessment and preterm delivery. Lancet (1994) 0.75
-Inguinal irradiation versus no lymph node therapy in small vulvar carcinoma with clinically negative lymph nodes (T1, NO-1)-. Gynakol Geburtshilfliche Rundsch (1995) 0.75
[Color Doppler flow measurements in uterine cancers]. Ultraschall Med (1991) 0.75
[Vaginal sonography of the cervix in twin pregnancies]. Geburtshilfe Frauenheilkd (1994) 0.75
[Ca 125 in epithelial ovarian cancers of FIGO stage I]. Gynakol Geburtshilfliche Rundsch (1993) 0.75
[The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma]. Wien Klin Wochenschr (1990) 0.75
Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor. Eur J Cancer (1998) 0.75
[A risk score for surgically treated stage Ib cervix carcinoma and its significance for postoperative irradiation]. Wien Klin Wochenschr (1990) 0.75
Influence of inflammatory reaction in primary fallopian-tube carcinoma (stage-I and stage-ii). Oncol Rep (1994) 0.75
Etoposide and carboplatin as salvage and first-line therapy in ovarian cancer patients. Ann Oncol (1993) 0.75
[The value of surgical staging in the early stages of ovarian carcinoma]. Wien Klin Wochenschr (1990) 0.75
[Surgical gynecologic interventions in females over 75 years of age]. Geburtshilfe Frauenheilkd (1986) 0.75
[Breech presentation in primiparous patients: indications for primary Cesarean section?]. Gynakol Geburtshilfliche Rundsch (1992) 0.75
[Breech presentation in nulliparous women--vaginal delivery or indications for primary section?]. Geburtshilfe Frauenheilkd (1993) 0.75
[Value of radical lymph node excision and postoperative therapy (chemotherapy vs. irradiation) in primary tubal cancer]. Gynakol Geburtshilfliche Rundsch (1994) 0.75
[Ovarian cancer after hysterectomy]. Gynakol Geburtshilfliche Rundsch (1993) 0.75
[Carboplatin, VP-16 in epithelial ovarian cancer--initial experiences]. Gynakol Rundsch (1988) 0.75
[The value of postoperative irradiation in endometrial cancer of pathohistologic stage I]. Geburtshilfe Frauenheilkd (1989) 0.75
[Isotope nephrogram in follow-up of radically operated cervix cancers]. Geburtshilfe Frauenheilkd (1993) 0.75
DNA ploidy in primary fallopian-tube carcinoma using image cytometry. Int J Cancer (1994) 0.75
-CA-125 antigen as a prognostic factor for survival in patients with epithelial ovarian carcinoma of FIGO stage I--preliminary results-. Geburtshilfe Frauenheilkd (1996) 0.75
Prognostic impact of DNA content and AUER classification in primary fallopian tube carcinoma. Cancer Lett (1995) 0.75
[After-care and palliative therapeutic measures in ovarian carcinoma]. Wien Med Wochenschr (1996) 0.75
[High-dose epirubicin in combination with high-dose ifosfamide plus granulocyte colony stimulating factor in patients with advanced platin-pretreated ovarian cancer. Phase I-II study]. Gynakol Geburtshilfliche Rundsch (1993) 0.75
[Primary irradiated adenocarcinoma of the uterine cervix]. Gynakol Rundsch (1989) 0.75
[Conization in pregnancy and its significance for the further course of pregnancy]. Geburtshilfe Frauenheilkd (1991) 0.75
[Survival prognosis in ovarian carcinoma Figo stages III and IV: 1980-1985 versus 1986-1993. A comparison of 2 treatment periods]. Gynakol Geburtshilfliche Rundsch (1997) 0.75
[Fallopian tube cancer--an Austrian multicenter study]. Gynakol Geburtshilfliche Rundsch (1992) 0.75
[Recombinant alpha and/or gamma interferon in the treatment of 45 patients with condylomata acuminata]. Gynakol Rundsch (1989) 0.75
[Effect of radiation therapy on urodynamic parameters in cervix cancer patients]. Gynakol Rundsch (1991) 0.75
[A risk score for operated endometrial cancer and its importance for adjuvant radiotherapy (histopathology and results of treatment based on 208 cases with pelvic lymph node excision)]. Geburtshilfe Frauenheilkd (1991) 0.75
[Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer]. Wien Klin Wochenschr (1993) 0.75
[PAP IV in pregnancy]. Gynakol Geburtshilfliche Rundsch (1992) 0.75
[Supportive measures for cytostatic therapy of gynecologic cancers]. Gynakol Rundsch (1991) 0.75
Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks. Gynecol Oncol (1995) 0.75
[Isotope nephrography in follow-up of cervix cancer patients after radical surgery]. Gynakol Rundsch (1991) 0.75
Reproductive performance after local and systemic prostaglandin for ectopic pregnancy. Arch Gynecol Obstet (1992) 0.75
[The CA-125 tumor marker in epithelial ovarian cancers of stage I]. Wien Klin Wochenschr (1993) 0.75
[Primary fallopian tube cancer--an Austrian multicenter study]. Geburtshilfe Frauenheilkd (1993) 0.75
[CA-12 tumor marker values in serum following radioimmuno-scintigraphy]. Gynakol Rundsch (1990) 0.75
[Effect of various factors on survival after recurrent and/or metastatic breast cancer]. Geburtshilfe Frauenheilkd (1991) 0.75
[Lymphoscintigraphy with (123)I-marked epidermal growth factor in cervix cancer]. Gynakol Geburtshilfliche Rundsch (1992) 0.75
[Cesarean section versus vaginal delivery of breech presentation in primiparous patients]. Gynakol Rundsch (1989) 0.75
Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Oncol (1994) 0.75
[Pap IV in pregnancy--a retrospective multicenter study]. Gynakol Rundsch (1990) 0.75
[Ovarian cancer following hysterectomy]. Gynakol Rundsch (1989) 0.75
[The prognostic effect of scintigraphy-guided lymphadenectomy in therapy of stage Ib cervix carcinoma]. Geburtshilfe Frauenheilkd (1995) 0.75